Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peterfy

Showing results (141-150 of 189) with videos related to

Pageof 19
Sort By:
Arthritis & Rheumatology (Hoboken, N.J.)|July 10, 2019
Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double-Blind, Randomized Controlled TrialRoy Fleischmann, Aileen L Pangan, In-Ho Song, et al.
Annals of the Rheumatic Diseases|September 7, 2011
Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trialJoel M Kremer, Anthony S Russell, Paul Emery, et al.
Arthritis Care & Research|April 15, 2010
Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patientsA Deodhar, R K Dore, D Mandel, et al.
Annals of the Rheumatic Diseases|February 12, 2016
Sustained improvements in MRI outcomes with abatacept following the withdrawal of all treatments in patients with early, progressive rheumatoid arthritisCharles Peterfy, Gerd R Burmester, Vivian P Bykerk, et al.
Seminars in Arthritis and Rheumatism|June 18, 2021
Reliability and agreement of proton density-weighted vs. gadolinium-enhanced T1-weighted MRI in hand osteoarthritis. An OMERACT MRI special interest group reliability exerciseØ Maugesten, S J Pedersen, M S Stoenoiu, et al.
Annals of the Rheumatic Diseases|August 24, 2012
Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trialPhilip G Conaghan, Patrick Durez, Rieke E Alten, et al.
The Journal of Rheumatology|December 3, 2013
Iterative development and reliability of the OMERACT hand osteoarthritis MRI scoring systemIda K Haugen, Mikkel Østergaard, Iris Eshed, et al.
Seminars in Arthritis and Rheumatism|June 17, 2026
Structural damage assessment in the spine of patients with axial spondyloarthritis - results from an international OMERACT multi-reader exercise using MRI-based synthetic CTSimone T Willesen, Robert G W Lambert, Walter P Maksymowych, et al.
The Journal of Rheumatology|September 3, 2011
OMERACT 10 Sharp Symposium: important findings in examination of imaging methods for measurement of joint damage in rheumatoid arthritisVibeke Strand, Sarah R Kingsbury, Thasia Woodworth, et al.
Magnetic Resonance Imaging|April 24, 1999
MR imaging of the arthritic rabbit knee joint using albumin-(Gd-DTPA)30 with correlation to histopathologyC F van Dijke, C G Peterfy, R C Brasch, et al.
Pageof 19

Showing results (141-150 of 189) with videos related to

Sort By:
Pageof 19
Arthritis & Rheumatology (Hoboken, N.J.)|July 10, 2019
Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double-Blind, Randomized Controlled TrialRoy Fleischmann, Aileen L Pangan, In-Ho Song, et al.
Annals of the Rheumatic Diseases|September 7, 2011
Long-term safety, efficacy and inhibition of radiographic progression with abatacept treatment in patients with rheumatoid arthritis and an inadequate response to methotrexate: 3-year results from the AIM trialJoel M Kremer, Anthony S Russell, Paul Emery, et al.
Arthritis Care & Research|April 15, 2010
Denosumab-mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patientsA Deodhar, R K Dore, D Mandel, et al.
Annals of the Rheumatic Diseases|February 12, 2016
Sustained improvements in MRI outcomes with abatacept following the withdrawal of all treatments in patients with early, progressive rheumatoid arthritisCharles Peterfy, Gerd R Burmester, Vivian P Bykerk, et al.
Seminars in Arthritis and Rheumatism|June 18, 2021
Reliability and agreement of proton density-weighted vs. gadolinium-enhanced T1-weighted MRI in hand osteoarthritis. An OMERACT MRI special interest group reliability exerciseØ Maugesten, S J Pedersen, M S Stoenoiu, et al.
Annals of the Rheumatic Diseases|August 24, 2012
Impact of intravenous abatacept on synovitis, osteitis and structural damage in patients with rheumatoid arthritis and an inadequate response to methotrexate: the ASSET randomised controlled trialPhilip G Conaghan, Patrick Durez, Rieke E Alten, et al.
The Journal of Rheumatology|December 3, 2013
Iterative development and reliability of the OMERACT hand osteoarthritis MRI scoring systemIda K Haugen, Mikkel Østergaard, Iris Eshed, et al.
Seminars in Arthritis and Rheumatism|June 17, 2026
Structural damage assessment in the spine of patients with axial spondyloarthritis - results from an international OMERACT multi-reader exercise using MRI-based synthetic CTSimone T Willesen, Robert G W Lambert, Walter P Maksymowych, et al.
The Journal of Rheumatology|September 3, 2011
OMERACT 10 Sharp Symposium: important findings in examination of imaging methods for measurement of joint damage in rheumatoid arthritisVibeke Strand, Sarah R Kingsbury, Thasia Woodworth, et al.
Magnetic Resonance Imaging|April 24, 1999
MR imaging of the arthritic rabbit knee joint using albumin-(Gd-DTPA)30 with correlation to histopathologyC F van Dijke, C G Peterfy, R C Brasch, et al.
Pageof 19